S. 494 (119th)Bill Overview

National Plan for Epilepsy Act

Health|Advisory bodiesCongressional oversight
Cosponsors
Support
Bipartisan
Introduced
Feb 10, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill creates a National Plan for Epilepsy within the Public Health Service Act to coordinate Federal research, prevention, diagnosis, treatment, and care for epilepsy. It requires an integrated plan, annual assessments, public reporting to Congress, and interagency data sharing.

Why people may split

Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost

Watch point

Noncontroversial health coordination bill with limited ideological hooks; funding questions could slow momentum.

This bill creates a National Plan for Epilepsy within the Public Health Service Act to coordinate Federal research, prevention, diagnosis, treatment, and care for epilepsy.

It requires an integrated plan, annual assessments, public reporting to Congress, and interagency data sharing.

The Secretary must establish an Advisory Council with Federal and non‑Federal members to meet quarterly and issue periodic reports.

Passage65/100

Mostly technical public-health coordination with bipartisan appeal; absence of explicit funding and legislative calendar/priorities create uncertainty.

CredibilityPartial

How solid the drafting looks.

Contention30/100

Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesImproved federal coordination could reduce duplicative epilepsy research and funding gaps.
  • Federal agenciesA national plan and annual reporting may clarify research priorities and guide federal investment.
  • Potential benefitEnhanced data sharing and surveillance could produce better epidemiology and targeted public‑health interventions.
Likely burdened
  • Federal agenciesImplementing the plan will create new federal administrative costs not explicitly funded in the text.
  • Potential burdenThe required reporting and coordination may increase regulatory or reporting burden on agencies and providers.
  • Federal agenciesThe plan risks duplicating or overlapping existing NIH, CDC, and other federal epilepsy activities.
03 · Why people split

Why the argument around this bill splits.

Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost
Progressive90%

Likely broadly supportive because the bill prioritizes research, care coordination, and addressing disparities for people with epilepsy.

It is welcomed for mandating public reporting, patient representation, and attention to outcomes, but advocates will note the absence of dedicated appropriations.

Leans supportive
Centrist80%

Generally supportive of an organized federal approach to a noncontroversial health problem, but cautious about costs, duplication, and measurable outcomes.

Values the bill's sunset, reporting requirements, and interagency coordination while wanting clear implementation plans and cost estimates.

Leans supportive
Conservative60%

Cautiously receptive because it targets a specific health need and includes DoD and VA involvement, but wary of expanding federal bureaucracy and unfunded mandates.

Prefers limited scope, fiscal restraint, and emphasis on state and private-sector roles.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood65/100

Mostly technical public-health coordination with bipartisan appeal; absence of explicit funding and legislative calendar/priorities create uncertainty.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • No explicit appropriation or cost estimate provided
  • Potential agency resource constraints and implementation capacity
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberty/justice emphasis vs cost concerns: liberals prioritize equity; conservatives worry about cost

Mostly technical public-health coordination with bipartisan appeal; absence of explicit funding and legislative calendar/priorities create…

Unlocked analysis

Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for National Plan for Epilepsy Act.

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis